Chemogenetic Inhibition of Infralimbic Prefrontal Cortex GABAergic Parvalbumin Interneurons Attenuates the Impact of Chronic Stress in Male Mice
Hypofunction of the prefrontal cortex (PFC) contributes to stress-related neuropsychiatric illnesses. Mechanisms leading to prefrontal hypoactivity remain to be determined. Prior evidence suggests that chronic stress leads to an increase in activity of parvalbumin (PV) expressing GABAergic interneur...
Saved in:
Published in | eNeuro Vol. 7; no. 5; p. ENEURO.0423-19.2020 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Society for Neuroscience
01.09.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Hypofunction of the prefrontal cortex (PFC) contributes to stress-related neuropsychiatric illnesses. Mechanisms leading to prefrontal hypoactivity remain to be determined. Prior evidence suggests that chronic stress leads to an increase in activity of parvalbumin (PV) expressing GABAergic interneurons (INs) in the PFC. The purpose of the study was to determine whether reducing PV IN activity in the Infralimbic (IL) PFC would prevent stress-related phenotypes. We used a chemogenetic approach to inhibit IL PFC PV INs during stress. Mice were first tested in the tail suspension test (TST) to determine the impact of PV IN inhibition on behavioral responses to acute stress. The long-term impact of PV IN inhibition during a modified chronic variable stress (CVS) was tested in the forced swim test (FST). Acute PV IN inhibition reduced active (struggling) and increased passive coping behaviors (immobility) in the TST. In contrast, inhibition of PV INs during CVS increased active and reduced passive coping behaviors in the FST. Moreover, chronic inhibition of PV INs attenuated CVS-induced changes in Fos expression in the prelimbic cortex (PrL), basolateral amygdala (BLA), and ventrolateral periaqueductal gray (vlPAG) and also attenuated adrenal hypertrophy and body weight loss associated with chronic stress. Our results suggest differential roles of PV INs in acute versus chronic stress, indicative of distinct biological mechanisms underlying acute versus chronic stress responses. Our results also indicate a role for PV INs in driving chronic stress adaptation and support literature evidence suggesting cortical GABAergic INs as a therapeutic target in stress-related illnesses. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 S. Martelle’s present address: Wake Forest Innovations, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States. Author contributions: N.N., E.M.C., S.M., R.D.M., and J.P.H. designed research; N.N., R.M., P.M., K.S.D., M.F., and B.A.P. performed research; N.N. and A.F.-V. contributed unpublished reagents/analytic tools; N.N., E.M.C., and K.S.D. analyzed data; N.N. and J.P.H. wrote the paper. The authors declare no competing financial interests. This work was supported by National Institute of Mental Health (NIMH) Grants R01-MH101729 and R01-MH048698 and by the United States Department of Veterans Affairs Grant I01BX003858 (to J.P.H.), NIMH Grants T32-NS-007453 and F31- MH123041 (to N.N.) and T32 DK059803 (to E.M.C.), Cohen Veterans Bioscience (S.M.), and a National Alliance for Research on Schizophrenia and Depression Young Investigator Award (R.D.M.). R. D. Moloney’s present address: School of Pharmacy, University College Cork, Cork, Ireland. |
ISSN: | 2373-2822 2373-2822 |
DOI: | 10.1523/ENEURO.0423-19.2020 |